Transcriptomic consequences of MDMX (MDM4) oncoprotein expression knockdown in MDMX-amplified breast cancer cells

被引：0
作者：
Ho, Yi-hsuan
Hutton, Claire
Newell, Herbie
Lunec, John
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-3701
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3701
引用
收藏
页数：3
相关论文
共 23 条
[21]   Dual-target MDM2/MDMX inhibitor increases the sensitization of doxorubicin and inhibits migration and invasion abilities of triple-negative breast cancer cells through activation of TAB1/TAK1/p38 MAPK pathway [J].
Fan, Yangwei ;
Li, Mengya ;
Ma, Ke ;
Hu, Yuan ;
Jing, Jiayu ;
Shi, Yu ;
Li, Enxiao ;
Dong, Danfeng .
CANCER BIOLOGY & THERAPY, 2019, 20 (05) :617-632
[22]   Recombinant Dual-target MDM2/MDMX Inhibitor Reverses Doxorubicin Resistance through Activation of the TAB1/TAK1/p38 MAPK Pathway in Wild-type p53 Multidrug-resistant Breast Cancer Cells [J].
Fan, Yangwei ;
Ma, Ke ;
Jing, Jiayu ;
Wang, Chuying ;
Hu, Yuan ;
Shi, Yu ;
Li, Enxiao ;
Geng, Qianqian .
JOURNAL OF CANCER, 2020, 11 (01) :25-40
[23]   Knockdown of cell division cycle-associated protein 4 expression inhibits proliferation of triple negative breast cancer MDA-MB-231 cells in vitro and in vivo [J].
Pang, Sen ;
Xu, Yuju ;
Chen, Jun ;
Li, Guibin ;
Huang, Jingle ;
Wu, Xianghua .
ONCOLOGY LETTERS, 2019, 17 (05) :4393-4400
123